Latest Articles

Publication Date
New endometriosis drug could offer 'breakthrough' alternative to hormones and surgery - Female First

New endometriosis drug could offer 'breakthrough' alternative to hormones and surgery Female First

Published: Oct. 6, 2026, 8:55 a.m.
New endometriosis drug could offer 'breakthrough' alternative to hormones and surgery - femalefirst.co.uk

New endometriosis drug could offer 'breakthrough' alternative to hormones and surgery femalefirst.co.uk

Published: Oct. 6, 2026, 8:55 a.m.
New drug for endometriosis could offer ‘breakthrough’ in treatment, scientists say - AOL.com

New drug for endometriosis could offer ‘breakthrough’ in treatment, scientists say AOL.com

Published: Oct. 2, 2026, 2:21 p.m.
New drug for endometriosis could offer ‘breakthrough’ in treatment, scientists say - aol.co.uk

New drug for endometriosis could offer ‘breakthrough’ in treatment, scientists say aol.co.uk

Published: Oct. 2, 2026, 2:21 p.m.
New drug for endometriosis could offer ‘breakthrough’ in treatment, scientists say - The Independent

New drug for endometriosis could offer ‘breakthrough’ in treatment, scientists say The Independent

Published: Oct. 2, 2026, 2:21 p.m.
New drug for endometriosis could offer ‘breakthrough’ in treatment, scientists say - independent.co.uk

New drug for endometriosis could offer ‘breakthrough’ in treatment, scientists say independent.co.uk

Published: Oct. 2, 2026, 2:21 p.m.
Fgl-1 Emerges as an Oncogenic Driver Fueling Endometrial Cancer Through PI3K/AKT Signaling - Bioengineer.org

Fgl-1 Emerges as an Oncogenic Driver Fueling Endometrial Cancer Through PI3K/AKT Signaling Bioengineer.org

Published: Sept. 23, 2026, 1:24 a.m.
Fgl-1 Emerges as an Oncogenic Driver Fueling Endometrial Cancer Through PI3K/AKT Signaling - bioengineer.org

Fgl-1 Emerges as an Oncogenic Driver Fueling Endometrial Cancer Through PI3K/AKT Signaling bioengineer.org

Published: Sept. 23, 2026, 1:24 a.m.
Endometriosis from Initiation to Innovation: Immune Microenvironments, Clonal Lesion Biology, and the Emerging Therapeutic Pipeline.

Endometriosis is a chronic, estrogen-dependent inflammatory disease that, despite its benign histology, displays several cancer-relevant features, including clonal expansion, somatic alteration-associated lesion evolution, tissue invasion, apoptosis resistance, immune evasion, angiogenesis, …

Published: Sept. 19, 2026, midnight
Breakthrough discovery detects endo in just 18 milliseconds - Adelaide Now

Breakthrough discovery detects endo in just 18 milliseconds Adelaide Now

Published: Sept. 15, 2026, 6:48 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!